CS logo
small CS logo
Specjalistyczna Przychodnia Lekarska "Medikard"

Plock, Poland
Medical clinic in Płock
Kolegialna 47, 09-402 Płock

About Specjalistyczna Przychodnia Lekarska "Medikard"


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Specjalistyczna Przychodnia Lekarska "Medikard"


During the past decade, Specjalistyczna Przychodnia Lekarska "Medikard" conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Specjalistyczna Przychodnia Lekarska "Medikard"" #1 collaborator was "Bausch Health Americas, Inc." with 1 trials as a collaborator and "Novartis" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at Specjalistyczna Przychodnia Lekarska "Medikard"


According to Clinical.Site data, the most researched conditions in "Specjalistyczna Przychodnia Lekarska "Medikard"" are "Cardiovascular Disease" (2 trials), "Anemia" (1 trials), "COPD" (1 trials), "Chronic Renal Insufficiency" (1 trials) and "Epilepsy" (1 trials). Many other conditions were trialed in "Specjalistyczna Przychodnia Lekarska "Medikard"" in a lesser frequency.

Clinical Trials Intervention Types at Specjalistyczna Przychodnia Lekarska "Medikard"


Most popular intervention types in "Specjalistyczna Przychodnia Lekarska "Medikard"" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials), "AD 237" (1 trials), "ERYPO" (1 trials) and "HX575 recombinant human erythropoietin alfa" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Specjalistyczna Przychodnia Lekarska "Medikard"


The vast majority of trials in "Specjalistyczna Przychodnia Lekarska "Medikard"" are 6 trials for "All" genders.

Clinical Trials Status at Specjalistyczna Przychodnia Lekarska "Medikard"


Currently, there are NaN active trials in "Specjalistyczna Przychodnia Lekarska "Medikard"". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Specjalistyczna Przychodnia Lekarska "Medikard", undefined suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Specjalistyczna Przychodnia Lekarska "Medikard", 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".